Shao Wenjun, Liu Xiaoni, Li Jiatong, Sheng Tianyang, Li Yarong, Gu Yuehua, Deng Bo, Wang Jingguo, Yang Wenbo, Yu Hai, Zhang Xiang, Chen Xiangjun
Department of Neurology, Huashan Hospital and Institute of Neurology, Fudan University, 12 Wulumuqi Zhong Road, Shanghai 200040, China.
Department of Neurology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China.
Heliyon. 2024 Jan 24;10(5):e24742. doi: 10.1016/j.heliyon.2024.e24742. eCollection 2024 Mar 15.
To analyze the immune parameters of cerebrospinal fluid (CSF) and oligoclonal band (OCB) type in patients with anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated diseases (MOGAD).
Patients who were seropositive for MOG-IgG and diagnosed with MOGAD according to the diagnosis criteria in the Department of Neurology, Huashan Hospital, Fudan University from December 2020 to June 2022 were retrospectively included in this study. Complete clinical data, blood and cerebrospinal fluid samples were collected from all the participants. Paired serum and CSF MOG-IgG and autoimmune encephalitis antibody were assayed by Cell Based Assay (CBA) based on transfected target antigens. Paired serum and CSF albumin and IgG were detected by turbidimetric scattering method, and OCB was detected by standard operation procedure as described.
A total of 86 patients (44 males and 42 females) with MOGAD were included in this study, with a median age of 30 years (range: 5-82 years). Among all the patients, 73 patients showed OCB type I, 12 patients showed OCB type II, and one patient showed OCB type III. The overall positive rate of CSF-OCB in MOGAD patients was 15.1 %. The 24-h intrathecal synthesis rate of CSF in the OCB-positive group (n = 13) was higher than that in the OCB-negative group [n = 73, 0.62 (0.26) vs 5.11 (13.67), = 0.003]. Subgroup analysis revealed that the positive rates of CSF-OCB in the single MOG group (n = 61) and the group combined with other antibodies (n = 25) were 14.8 % and 16.0 %, respectively. The incidence of meningoencephalitis (13/61 vs 13/25, = 0.011) was significantly different between the two groups. The proportion of patients with high (≥1:32) or low (≤1:10) CSF MOG-IgG also showed significant difference in the group combined with other antibodies ( = 0.032). Optic neuritis was more common in the relapse course group (n = 49) than the monophasic course group (n = 37, < 0.001) No significant diferences of CSF immune parameters were found in the MOG-IgG group and the MOG-IgG group, and the titer of MOG-IgG in the serum or CSF did not influence CSF immune parameters in different subgroups.
The overall positive rate of CSF-OCB in MOGAD patients was 15.1 %. The 24-h intrathecal synthesis rate of cerebrospinal fluid in the OCB-positive group was higher than that in the OCB-negative group. This study illustrated OCB characterization in MOGAD patients, and will shed light on the standardization of OCB test in the study of immune diseases.
分析抗髓鞘少突胶质细胞糖蛋白(MOG)抗体相关疾病(MOGAD)患者脑脊液(CSF)的免疫参数及寡克隆带(OCB)类型。
回顾性纳入2020年12月至2022年6月在复旦大学附属华山医院神经内科根据诊断标准确诊为MOGAD且MOG-IgG血清学阳性的患者。收集所有参与者的完整临床资料、血液和脑脊液样本。基于转染靶抗原,采用细胞法检测配对血清和脑脊液中的MOG-IgG及自身免疫性脑炎抗体。采用散射比浊法检测配对血清和脑脊液中的白蛋白及IgG,按照标准操作流程检测OCB。
本研究共纳入86例MOGAD患者(男性44例,女性42例),中位年龄30岁(范围:5 - 82岁)。所有患者中,73例显示为I型OCB,12例显示为II型OCB,1例显示为III型OCB。MOGAD患者脑脊液OCB总体阳性率为15.1%。OCB阳性组(n = 13)脑脊液24小时鞘内合成率高于OCB阴性组[n = 73,0.62(0.26)对5.11(13.67),P = 0.003]。亚组分析显示,单纯MOG组(n = 61)和合并其他抗体组(n = 25)脑脊液OCB阳性率分别为14.8%和16.0%。两组间脑膜脑炎发病率(13/61对13/25,P = 0.011)差异有统计学意义。合并其他抗体组中脑脊液MOG-IgG高滴度(≥1:32)或低滴度(≤1:10)患者比例也有显著差异(P = 0.032)。复发病程组(n = 49)视神经炎较单相病程组(n = 37,P < 0.001)更常见。MOG-IgG阳性组和MOG-IgG阴性组脑脊液免疫参数无显著差异,血清或脑脊液中MOG-IgG滴度不影响不同亚组的脑脊液免疫参数。
MOGAD患者脑脊液OCB总体阳性率为15.1%。OCB阳性组脑脊液24小时鞘内合成率高于OCB阴性组。本研究阐明了MOGAD患者的OCB特征,将为免疫疾病研究中OCB检测的标准化提供参考。